70 related articles for article (PubMed ID: 22242438)
21. Comparative efficacy of three antiviral drugs in mice herpetic keratitis.
Inoue Y; Ohashi Y; Shimomura Y; Manabe R; Yamada M; Ueda S; Kato S
Jpn J Ophthalmol; 1989; 33(1):125-31. PubMed ID: 2543857
[TBL] [Abstract][Full Text] [Related]
22. [Comparison of therapeutic activity of idoxuridine and acyclovir in experimentally-induced herpetic keratitis in rabbits (author's transl)].
Colin C; Chastel C; Quillien MC; Renard G
J Fr Ophtalmol; 1981; 4(1):33-43. PubMed ID: 7217623
[TBL] [Abstract][Full Text] [Related]
23. Ganciclovir ophthalmic gel (Virgan; 0.15%) in the treatment of herpes simplex keratitis.
Colin J; Hoh HB; Easty DL; Herbort CP; Resnikoff S; Rigal D; Romdane K
Cornea; 1997 Jul; 16(4):393-9. PubMed ID: 9220235
[TBL] [Abstract][Full Text] [Related]
24. Effect of acyclovir on acute and latent herpes simplex virus infections in the rabbit.
Trousdale MD; Dunkel EC; Nesburn AB
Invest Ophthalmol Vis Sci; 1980 Nov; 19(11):1336-41. PubMed ID: 7429768
[TBL] [Abstract][Full Text] [Related]
25. [The new interferon inducer Aktipol in the treatment of herpetic keratitis].
Akberova SI; Musaev Galbinur PI
Vestn Oftalmol; 2000; 116(2):16-8. PubMed ID: 11055216
[TBL] [Abstract][Full Text] [Related]
26. [The efficacy of acyclovir treatment in the therapy of herpetic keratitis].
Turlea M; Raica D; Haidar A
Oftalmologia; 1999; 49(4):55-8. PubMed ID: 11021286
[TBL] [Abstract][Full Text] [Related]
27. [Pharmacokinetics and antiviral activity of riodoksol in an ointment and in ophthalmic drug films in ocular herpes].
Shchipanova AI; Maĭchuk IuF; Nikolaeva IS; Pershin GN
Farmakol Toksikol; 1981; 44(4):439-42. PubMed ID: 7286202
[TBL] [Abstract][Full Text] [Related]
28. Comparison of oral antiviral therapy with valacyclovir or acyclovir after penetrating keratoplasty for herpetic keratitis.
Goldblum D; Bachmann C; Tappeiner C; Garweg J; Frueh BE
Br J Ophthalmol; 2008 Sep; 92(9):1201-5. PubMed ID: 18650215
[TBL] [Abstract][Full Text] [Related]
29. Acyclovir for the prevention of recurrent herpes simplex virus eye disease. Herpetic Eye Disease Study Group.
N Engl J Med; 1998 Jul; 339(5):300-6. PubMed ID: 9696640
[TBL] [Abstract][Full Text] [Related]
30. [Antiviral therapy adjustment in corneal recipients using antibody testing in the aqueous humor].
Robert PY; Liekfeld A; Ranger-Rogez S; Jaekel C; Pleyer U; Adenis JP; Hartmann C
J Fr Ophtalmol; 2003 Apr; 26(4):350-4. PubMed ID: 12843891
[TBL] [Abstract][Full Text] [Related]
31. A systematic review and meta-analysis to compare the efficacy of acyclovir 3% ophthalmic ointment to idoxuridine in curing herpetic keratitis by Day 7 of treatment.
Balderson DE; Cai G; Fries MA; Kleinman DM; McLaughlin MM; Trivedi TM; Wurzelmann JI; Young SB
BMC Ophthalmol; 2015 Apr; 15():42. PubMed ID: 25928630
[TBL] [Abstract][Full Text] [Related]
32. [Penetrating keratoplasty in active herpes simplex stromal keratitis].
Dong X; Shi W; Xie L
Zhonghua Yan Ke Za Zhi; 2001 Mar; 37(2):118-20. PubMed ID: 11864405
[TBL] [Abstract][Full Text] [Related]
33. The role of a HSV thymidine kinase stimulating substance, scopadulciol, in improving the efficacy of cancer gene therapy.
Hayashi K; Lee JB; Maitani Y; Toyooka N; Nemoto H; Hayashi T
J Gene Med; 2006 Aug; 8(8):1056-67. PubMed ID: 16779868
[TBL] [Abstract][Full Text] [Related]
34. In vivo ocular pharmacokinetics of acyclovir dipeptide ester prodrugs by microdialysis in rabbits.
Anand BS; Katragadda S; Gunda S; Mitra AK
Mol Pharm; 2006; 3(4):431-40. PubMed ID: 16889437
[TBL] [Abstract][Full Text] [Related]
35. Altering clinical features of recurrent herpes simplex virus-induced keratitis.
Uchio E; Hatano H; Ohno S
Ann Ophthalmol; 1993 Jul; 25(7):271-6. PubMed ID: 8395784
[TBL] [Abstract][Full Text] [Related]
36. Evaluation of 1-(2'-deoxy-2'-fluoro-beta-D-arabinofuranosyl)-5-ethyluracil in a rabbit model of herpetic keratitis.
Trousdale MD; Law JL; Yarber FA; Watanabe KA; Fox JJ
Antiviral Res; 1992 Feb; 17(2):157-67. PubMed ID: 1313221
[TBL] [Abstract][Full Text] [Related]
37. Use of nucleoside analogues in the treatment of herpes simplex virus eye diseases.
Sundmacher R
Metab Pediatr Syst Ophthalmol; 1983; 7(2):89-94. PubMed ID: 6686278
[TBL] [Abstract][Full Text] [Related]
38. Acyclovir for recurrent herpes simplex virus ocular disease.
Jabs DA
N Engl J Med; 1998 Jul; 339(5):340-1. PubMed ID: 9682049
[No Abstract] [Full Text] [Related]
39. Effect of oral acyclovir after penetrating keratoplasty for herpetic keratitis: a placebo-controlled multicenter trial.
van Rooij J; Rijneveld WJ; Remeijer L; Völker-Dieben HJ; Eggink CA; Geerards AJ; Mulder PG; Doornenbal P; Beekhuis WH
Ophthalmology; 2003 Oct; 110(10):1916-9; discussion 1919. PubMed ID: 14522763
[TBL] [Abstract][Full Text] [Related]
40. Pharmacokinetics of oral acyclovir in neonates and in infants: a population analysis.
Tod M; Lokiec F; Bidault R; De Bony F; Petitjean O; Aujard Y
Antimicrob Agents Chemother; 2001 Jan; 45(1):150-7. PubMed ID: 11120958
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
